Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

The Influence of Immunomodulatory Diets on Transplant Success and Complications

Go back to Resources

The Influence of Immunomodulatory Diets on Transplant Success and Complications

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Safety and Immunogenicity of MVA.HIVA by 3 Different Routes

Go back to Resources

Safety and Immunogenicity of MVA.HIVA by 3 Different Routes

Authors:

Secondary:

Location:

Go back to Resources

Risk Factors Associated with the Incidence of Age-Related Macular Degeneration in The Age-Related Eye Disease Study (AREDS) AREDS Report No. 19

Go back to Resources

Risk Factors Associated with the Incidence of Age-Related Macular Degeneration in The Age-Related Eye Disease Study (AREDS) AREDS Report No. 19

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Review of Hemostatic Agents Used in Dentistry

Go back to Resources

Review of Hemostatic Agents Used in Dentistry

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Go back to Resources

C-Reactive Protein and Homocysteine are Associated With Dietary and Behavioral Risk Factors for Age-Related Macular Degeneration

Go back to Resources

C-Reactive Protein and Homocysteine are Associated With Dietary and Behavioral Risk Factors for Age-Related Macular Degeneration

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss

Go back to Resources

Baseline Patient Characteristics in the PKC-DRS2 Trial: The Effect of The PKC-b Inhibitor Ruboxistaurin on Moderate Visual Loss

Authors:

Secondary:

Location:

URL:

Go back to Resources

A Rabbit Model for Assessing the Ocular Barriers to the Transscleral Delivery of Triamcinolone Acetonide

Go back to Resources

A Rabbit Model for Assessing the Ocular Barriers to the Transscleral Delivery of Triamcinolone Acetonide

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A Phase I Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimeric Vaccines

Go back to Resources

A Phase I Study of 4 Live, Recombinant Human Cytomegalovirus Towne/Toledo Chimeric Vaccines

Authors:

Secondary:

Volume:

Pagination:

URL:

Keywords:

Abstract:

Go back to Resources

A Novel and Efficient Site Selection Process for a Large Multi-Center Trial

Go back to Resources

A Novel and Efficient Site Selection Process for a Large Multi-Center Trial

Authors:

Secondary:

Location:

Go back to Resources

Umbilical Cord Blood Transplantation in Pediatric Patients with Malignant Diseases: Results of a Prospective, Multi-Institutional NHLBI Sponsored Trial

Go back to Resources

Umbilical Cord Blood Transplantation in Pediatric Patients with Malignant Diseases: Results of a Prospective, Multi-Institutional NHLBI Sponsored Trial

Authors:

Secondary:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 152
  • Page 153
  • Page 154
  • Page 155
  • Current page 156
  • Page 157
  • Page 158
  • Page 159
  • Page 160
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions

Cookie Policy

Our site uses cookies for analytics and to improve our site and services. You can manage these cookies via your browser settings at any time. By continuing to use our site, you agree to our use of cookies. For more information, including how to change your settings, see our Cookie Policy.